Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on uveomeningoencephalitides.

Shwu-Jiuan Sheu1

  • 1Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung School of Medicine, National Yang-Ming University, Taipei, Taiwan. sjsheu@isca.vghks.gov.tw

Current Opinion in Neurology
|May 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology and disease patterns of uveitis in Taiwan: A nationwide multicenter analysis.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same author

Associations Between Initial Glycated Hemoglobin at Diabetes Diagnosis, Longitudinal Changes and Medication Effects, and the Severity and Progression of Sight-Threatening Diabetic Retinopathy.

The Kaohsiung journal of medical sciences·2025
Same author

A delphi consensus study for treatment of full-thickness macular hole in Taiwan.

Scientific reports·2025
Same author

Analysis of retinal microstructure and electrophysiology in eyes following pars plana vitrectomy and membrane peeling for vitreomacular interface disorders.

BMC ophthalmology·2025
Same author

Chinese translation validation of the adherence barrier questionnaire (intravitreal anti-vascular endothelial growth factor therapy) in Taiwan.

The Kaohsiung journal of medical sciences·2024
Same author

<i>Helicobacter pylori</i> and Its Treatment Impact on Immune-Mediated Ocular Diseases.

Ocular immunology and inflammation·2024
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Vogt-Koyanagi-Harada (VKH) disease, an autoimmune disorder, involves the eyes, brain, and skin. Early diagnosis and prompt corticosteroid treatment improve visual outcomes, though optimal therapy requires further study.

Area of Science:

  • Ophthalmology
  • Neurology
  • Immunology

Background:

  • Vogt-Koyanagi-Harada (VKH) disease is a chronic, bilateral granulomatous panuveitis affecting multiple systems.
  • While visual prognosis is often favorable, patient outcomes and treatment strategies vary globally.
  • This review synthesizes current literature on VKH disease pathogenesis, diagnosis, and management.

Purpose of the Study:

  • To review the literature on the pathogenesis, diagnosis, and treatment of Vogt-Koyanagi-Harada (VKH) disease.
  • To discuss diagnostic criteria and emerging techniques for VKH disease.
  • To evaluate current and novel therapeutic approaches for VKH disease.

Main Methods:

  • Literature review of studies on Vogt-Koyanagi-Harada (VKH) disease.
  • Analysis of diagnostic criteria revisions and new diagnostic techniques.

Related Experiment Videos

  • Evaluation of various treatment strategies, including corticosteroids and adjuvant therapies.

    • Main Results:

    • VKH disease is increasingly recognized as an autoimmune disorder with varied presentations, including atypical forms and those linked to interferon-alpha therapy.
    • Revised diagnostic criteria (1999 International Workshop) accommodate diverse ocular findings across disease stages.
    • Corticosteroid therapy, administered via different routes with adjuvant treatments, shows positive results in managing VKH disease.

    Conclusions:

    • The autoimmune nature of VKH disease is strongly suggested, despite uncertain pathogenesis and lack of antigen-specific treatments.
    • Systemic corticosteroid therapy remains the primary initial treatment, with varied administration routes and adjuvant options to mitigate side effects.
    • Early diagnosis and prompt, appropriate treatment are crucial for better visual outcomes; further large-scale studies are needed to optimize initial therapy.